CX3CR1 and obesity disorder: Furthermore, surface expression of CX3CR1 was measured and revealed significantly increased CX3CR1 expression levels on CMs (p = 0.0205) and NCMs (p = 0.0223) from patients with obesity compared with healthy donors (Fig. 4C).